1. (1) DEQ may require a proposed drug take-back program plan and updated program plan submitted under ORS 459A.209 to include the Oregon Board of Pharmacy registration number issued for each covered manufacturer participating in the proposed drug take-back program, or a statement that the manufacturer is not required to register with the Oregon Board of Pharmacy.
2. (2) For purposes of ORS 459A.209(4), reasonably convenient and equitable access to all residents includes access for minority, lower-income, rural and other historically underserved communities.
3. (3) A proposed drug take-back program plan and updated program plan submitted under ORS 459A.209 must include a goal for fostering public awareness in minority, lower-income, rural and other historically underserved communities.

Statutory/Other Authority

HB 3273 (2019), ORS 468.020, ORS 468.065, ORS 459A.266 & HB3273 (2019)

Statutes/Other Implemented

HB 3273 (2019), ORS 459A.203, ORS 459A.209, ORS 459A.212, ORS 459A.215, ORS 459A.218, ORS 459A.239, ORS 459A.242 & HB3273 (2019)

History

DEQ 18-2020, adopt filed 09/21/2020, effective 09/21/2020